School of Biomedical Sciences - Faculty of Medicine and Health Sciences

Hannah Garner receives 2026 Terry Fox New Investigator Award

The Terry Fox Research Institute — Fri, 27 Mar 2026 19:09:30 +0000

Breast cancer and high-grade serous ovarian cancer are leading causes of cancer-related death in women. For many families, these diagnoses are linked to inherited mutations, or mistakes, in the BRCA1 gene. This gene appears in every cell of the body and plays a critical role in repairing damaged DNA. Normally, cells carry two copies of the BRCA1 gene, so if one doesn’t function properly, the other can act as a backup. However, if additional mutations occur, this repair system can fail, allowing cancer to develop.

Big federal funding for FMHS cancer prevention research

Robin Koning — Fri, 27 Feb 2026 20:12:07 +0000

Four ��VR��Ƶ researchers have received $7.9 million total in funding from the Canadian Institutes of Health Research (CIHR) and partners through the Bringing Biology to Cancer Prevention Team Grants program, announced today by the Honourable Marjorie Michel, Canada’s Minister of Health.

Engineered nanoparticles could deliver better targeted cancer treatment

��VR��Ƶ Newsroom — Fri, 27 Feb 2026 20:05:12 +0000

Scientists at ��VR��Ƶ and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard treatment in a preclinical study.

Ahmad Haidar awarded funding to study tirzepatide in Type 1 diabetes

The Institute — Fri, 27 Feb 2026 20:01:11 +0000

Managing blood sugar after meals remains one of the most demanding parts of daily life for people living with Type 1 diabetes — even for those using automated insulin delivery systems. New research led by Ahmad Haidar, PhD, aims to test whether adding tirzepatide, a medication that slows digestion, could reduce the need for manual mealtime insulin dosing while maintaining effective glucose control.

��VR��Ƶ and Moderna launch breakthrough RNA project through D2R to advance made-in-Canada innovation

D2R — Fri, 27 Feb 2026 19:57:21 +0000

��VR��Ƶ researchers, supported by the DNA to RNA (D2R) initiative and Moderna, are launching a pioneering research project that aims to further the fundamentals of ribonucleic acid (RNA) medicines by enhancing our understanding of the three-dimensional structure of full-length messenger RNA (mRNA).

$55.9M in CIHR grants for FMHS research

��VR��Ƶ Research + Innovation — Thu, 12 Feb 2026 18:53:24 +0000

The Canadian Institutes of Health Research (CIHR) announced a total national investment of $413 million through the CIHR Fall 2025 Project Grant competition, funding 421 grants. At ��VR��Ƶ, 56 projects were funded for a total research investment of $55.9 million.

Four ��VR��Ƶ studies make Québec Science’s list of the Top 10 Discoveries of the Year

Stephanie Wereley — Fri, 16 Jan 2026 17:29:08 +0000

Québec Science magazine has published its list of 2025’s Top 10 breakthroughs by Quebec researchers. Four ��VR��Ƶ research papers, including one from the Faculty of Medicine and Health Sciences, are listed.

Their topics range from prehistoric fossils to female fertility, highlighting the range of expertise at the University.

Cancer Research Society invests in ��VR��Ƶ discoveries

Frédéric Feknous — Fri, 16 Jan 2026 17:19:33 +0000

Twenty-two FMHS researchers have received funding from the Cancer Research Society (CRS) through its Operating Grants competition, announced on November 20.

From the bench to the beach

Neale McDevitt — Fri, 28 Nov 2025 19:32:33 +0000

As many Canadians trade snow for surf over the Christmas break, few think about the painful surprises that can come with a beach vacation. Jellyfish, fire coral and the invasive lionfish can turn a sunny afternoon into a medical emergency, with pain strong enough to cut a trip short.

��VR��Ƶ researchers contribute to international study on DNA synthesis

CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences — Fri, 21 Nov 2025 17:26:26 +0000

Inside every cell, a finely tuned metabolic network determines when to build, recycle, or stop producing essential molecules. A central part of this network is folate metabolism, which provides vital chemical units for the synthesis of DNA, RNA and amino acids. When this system is disturbed – through genetic mutations or a lack of dietary folates – the consequences can range from developmental disorders to cancer.